Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

 64.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 64.60
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 126,403
  • Market Cap: £348.66m
  • RiskGrade: 119
  • Beta: 0.01

Latest ShareCast News

Alliance Pharma confident despite softer sales

By Abigail Townsend

Date: Tuesday 08 Apr 2025

(Sharecast News) - Alliance Pharma posted weaker full-year revenues on Tuesday, but insisted it remained well-positioned for medium-term growth.

Alliance Pharma Regulatory News

Form 8.3 - [ALLIANCE PHARMA PLC - 28 04 2025] - ... 29-Apr-2025 12:21 GlobeNewswire NA
Form 8.3 - Alliance Pharma PLC 29.04.2025 29-Apr-2025 11:50 RNS
Form 8.3 - Alliance Pharma PLC 29-Apr-2025 10:37 RNS
Form 8.5 (EPT/RI) - Alliance Pharma plc 29-Apr-2025 10:09 RNS
Form 8.5 (EPT/RI) - Alliance Pharma plc 29-Apr-2025 08:49 GlobeNewswire NA

Alliance Pharma News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 64.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 64.60
52 Week Low 29.35
Volume 126,403
Shares Issued 540.57m
Market Cap £348.66m
Beta 0.01
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.92% above the market average23.92% above the market average23.92% above the market average23.92% above the market average23.92% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
84.17% above the market average84.17% above the market average84.17% above the market average84.17% above the market average84.17% above the market average
91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average
Income Not Available
Growth
50.9% below the market average50.9% below the market average50.9% below the market average50.9% below the market average50.9% below the market average
56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 5
Sell 1
Strong Sell 0
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 29-Apr-2025

Time Volume / Share Price
11:38 28,839 @ 64.41p
11:35 2,265 @ 64.50p
11:35 4,378 @ 64.50p
11:33 14,755 @ 64.41p
11:32 5,074 @ 64.50p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page